Individualized Treatment-Adjusted Risk Stratification in Newly Diagnosed Multiple Myeloma

被引：3

作者：

Maura, Francesco ^{[1
]}

Rajanna, Arjun Raj ^{[1
]}

Derkach, Andriy ^{[2
]}

Ziccheddu, Bachisio ^{[3
]}

Weinhold, Niels ^{[4
]}

Maclachlan, Kylee H. ^{[5
]}

Diamond, Benjamin ^{[1
]}

Davies, Faith E. ^{[6
]}

Boyle, Eileen ^{[6
]}

Walker, Brian A. ^{[7
]}

Poos, Alexandra M. ^{[4
]}

Hultcrantz, Malin ^{[5
]}

Silva, Ariosto Siqueira ^{[8
]}

Hampton, Oliver ^{[9
]}

Teer, Jamie ^{[8
]}

Bolli, Niccolo ^{[10
,11
]}

Jackson, Graham ^{[12
]}

Kaiser, Martin F. ^{[13
]}

Pawlyn, Charlotte ^{[13
]}

Cook, Gordon ^{[14
]}

Verducci, Dennis ^{[1
]}

Kazandjian, Dickran ^{[1
]}

van Rhee, Frits ^{[15
]}

Usmani, Saad ^{[16
]}

Shain, Ken H. ^{[8
]}

Raab, Marc S. ^{[4
]}

Morgan, Gareth J. ^{[6
]}

Landgren, Ola ^{[3
]}

机构：

[1] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Div, Miami, FL USA

[2] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA

[3] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Serv, Miami, FL USA

[4] Univ Hosp Heidelberg, Dept Internal Med 5, Multiple Myeloma Res Grp, Heidelberg, Germany

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[6] NYU Langone, Perlmutter Canc Ctr, New York, NY USA

[7] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Div Hematol Oncol, Indianapolis, IN 46204 USA

[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[9] M2GEN, Tampa, FL USA

[10] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol Unit, Milan, Italy

[11] Univ Milan, Milan, Italy

[12] Dept Haematol, NCCC Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England

[13] Inst Canc Res, London, England

[14] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England

[15] Univ Arkansas Med Sci, Myeloma Ctr, Little Rock, AR 72205 USA

[16] Mem Sloan Kettering Canc Ctr, Myeloma Serv, New York, NY USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-160215

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1561 / 1563

页数：3

共 50 条

[1] Individualized risk stratification in newly diagnosed multiple myeloma
Rajanna, Arjun Raj
Maura, Francesco
Derkach, Andriy
Ziccheddu, Bachisio
Weinhold, Niels
Maclachlan, Kylee
Diamond, Benjamin
Davies, Faith
Boyle, Eileen
Walker, Brian
Pos, Alexandra
Hulcrantz, Malin
Silva, Ariosto
Hampton, Oliver
Teer, Jamie K.
Bolli, Niccolo
Jackson, Graham
Kaiser, Martin
Pawlyn, Charlotte
Cook, Gordon
Verducci, Dennis
Kazandjian, Dickran
Van Rhee, Fritz
Usmani, Saad
Shain, Kenneth H.
Raab, Marc S.
Morgan, Gareth
Landgren, Ola
CANCER RESEARCH, 2023, 83 (07)
[2] Individualized risk in newly diagnosed multiple myeloma
Maura, Francesco
Rajanna, Arjun
Ziccheddu, Bachisio
Derkach, Andriy
Poos, Alexandra
Maclachlan, Kylee
Boyle, Eileen
Hultcrantz, Malin
Silva, Ariosto
Jackson, Graham
Kaiser, Martin
Pawlyn, Charlotte
Cook, Gordon
Bergsagel, Leif
Goldschmidt, Hartmut
Weisel, Katja
Fenk, Roland
Mai, Elias
Raab, Marc
van Rhee, Frits
Usmani, Saad
Shain, Ken
Weinhold, Niels
Morgan, Gareth
Landgren, Ola
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S236 - S236
[3] Update on risk stratification and treatment of newly diagnosed multiple myeloma
Prashant Kapoor
S. Vincent Rajkumar
International Journal of Hematology, 2011, 94 : 310 - 320
[4] Update on risk stratification and treatment of newly diagnosed multiple myeloma
Kapoor, Prashant
Rajkumar, S. Vincent
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (04) : 310 - 320
[5] Management of Newly Diagnosed Multiple Myeloma Based on Risk Stratification
Callander, Natalie S.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 : 17 - 19
[6] Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
Mellors, Patrick
Binder, Moritz
Ketterling, Rhett P.
Griepp, Patricia
Baughn, Linda B.
Buadi, Francis K.
Lacy, Martha Q.
Gertz, Morie A.
Dispenzieri, Angela
Haymann, Suzanne
Kapoor, Prashant
Gonsalves, Wilson I.
Hwa, Yi Lisa
Fonder, Amie
Hobbs, Miriam A.
Kourelis, Taxiarchis
Warsame, Rahma M.
Lust, John A.
Leung, Nelson
Go, Ronald S.
Kyle, Robert A.
Rajkumar, S. Vincent
Kumar, Shaji K.
BLOOD, 2019, 134
[7] Development of a Clinical Risk Stratification for Patients with Newly Diagnosed Multiple Myeloma
Mao, Xuehan
Xu, Yan
Yan, Yuting
Liu, Jiahui
Fan, Huishou
Sui, Weiwei
Deng, Shuhui
Li, Zengjun
Qiu, Lugui
An, Gang
BLOOD, 2019, 134
[8] Risk stratification of patients with newly diagnosed multiple myeloma: Optimizing treatment based on pretreatment characteristics
Chng, Wee J.
Fonseca, Rafael
CLINICAL LYMPHOMA & MYELOMA, 2005, 6 (03): : 200 - 207
[9] Machine learning assisted risk stratification of newly diagnosed multiple myeloma with respect to the VRd treatment
Koo, Jamin
Choi, Gyucheol
Park, Sung-Soo
Byun, Ja Min
Lim, Sungwon
Lee, Jong Cheol
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S100 - S101
[10] Radiomics-Based Biomarkers for Risk Stratification in Newly Diagnosed Multiple Myeloma
Shreve, Jacob T.
Howe, Michael D.
Guzman, Emmanuel Contreras
Charalampous, Charalampos
Gonsalves, Wilson I.
Buadi, Francis
Kourelis, Taxiarchis
Hayman, Suzanne R.
Gertz, Morie A.
Fonseca, Rafael
Rajkumar, S. Vincent
Dasari, Surendra
Thorpe, Matthew P.
Broski, Stephen
Kumar, Shaji
Binder, Moritz
BLOOD, 2024, 144 : 4711 - 4712

← 1 2 3 4 5 →